iRhythm Technologies, Inc.
iRhythm Technologies, Inc.
Your view on IRTC
Overview
What the company does, where it operates, and who runs it.
About iRhythm Technologies, Inc.
- Industry
- Medical - Devices
- Sector
- Healthcare
- CEO
- Quentin S. Blackford
- Headquarters
- 699 8th Street, San Francisco, CA, US
- Industry
- Medical - Devices
- Sector
- Healthcare
- CEO
- Quentin S. Blackford
- Headquarters
- 699 8th Street, San Francisco, CA, US
iRhythm Technologies, Inc., a digital healthcare company, provides ambulatory electrocardiogram (ECG) monitoring products for patients at risk for arrhythmias in the United States.
It offers Zio service, an ambulatory cardiac monitoring solution that combines a wire-free, patch-based, and wearable biosensor with a cloud-based data analytic platform to help physicians to monitor patients and diagnose arrhythmias.
The company's Zio XT and AT monitors, a single-use, wire-free, and wearable patch-based biosensors, records patient's heartbeats and ECG data. It has a development collaboration agreement with Verily Life Sciences LLC to develop various next-generation atrial fibrillation screening, detection, or monitoring products.
The company was incorporated in 2006 and is headquartered in San Francisco, California.
Media
Infographics, videos, and posts covering the company.
Stock Data
Price chart, volume, and trading data.
Fair Value
What FRC thinks it is worth vs. the current price.
FRC's fair value estimate for iRhythm Technologies, Inc., and the rating behind it. IRTC last traded at $111.43; the estimate is read against that market price. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
Valuation, profitability, liquidity and leverage ratios for iRhythm Technologies, Inc.. Starting points for iRhythm Technologies, Inc.: EPS -$0.42, beta 1.32 — an Medical - Devices name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
Dividend history, yield and payout sustainability for iRhythm Technologies, Inc.. iRhythm Technologies, Inc. does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
Reported vs. expected earnings history for iRhythm Technologies, Inc.. Trailing twelve-month EPS for iRhythm Technologies, Inc. stands at -$0.42. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Financial Statements
Income statement, balance sheet, and cash flow statements.
Income statement, balance sheet and cash flow history for iRhythm Technologies, Inc.. iRhythm Technologies, Inc. has reported as a listed company since 2016. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
iRhythm Technologies, Inc. valued side by side against its closest peers. iRhythm Technologies, Inc. is measured against Medical - Devices peers within the Healthcare sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.
Institutional Ownership
PremiumWhich funds and firms own the stock.
Which institutions hold iRhythm Technologies, Inc., and how their positions are changing. At a $3.66B market value, institutional positions materially move iRhythm Technologies, Inc.'s register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings. Included with FRC Premium.
Insider Trading
PremiumRecent buying and selling by company executives.
Buying and selling by iRhythm Technologies, Inc. executives and directors. Shares of iRhythm Technologies, Inc. have traded between $71.00 and $212.00 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned. Included with FRC Premium.
Senate Trading
PremiumU.S. Senator disclosures filed under the STOCK Act.
U.S. Senate disclosures naming iRhythm Technologies, Inc.. iRhythm Technologies, Inc. is a $3.66B Healthcare company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely. Included with FRC Premium.
House Trading
PremiumU.S. Representative disclosures filed under the STOCK Act.
U.S. House of Representatives disclosures naming iRhythm Technologies, Inc.. Representatives' reported transactions in this security, shown next to the company's fundamentals. Included with FRC Premium.
News
Latest headlines and market coverage.
Latest headlines and company announcements for iRhythm Technologies, Inc.. Coverage tracks iRhythm Technologies, Inc. within Medical - Devices (Healthcare). Press releases and market coverage, newest first.